April 2022 – AMSL Diabetes is excited to announce the launch of Control-IQ™ technology for the t:slim X2™ insulin pump!
The t:slim X2 insulin pump (compatible with Dexcom G6 continuous glucose monitoring) is capable of remote feature updates.* Recently, we welcomed the newest software to launch within Australia; Control-IQ.
Control-IQ technology is an advanced hybrid closed-loop technology that helps to keep glucose levels in range^ (3.9 to 10 mmol/L) by predicting glucose levels 30 minutes ahead and adjusting insulin delivery according, to help prevent both high and low glucose events.
You can expect the same features from the t:slim X2 insulin pump with Control-IQ technology, such as the large colour touchscreen, slim design, rechargeable battery and micro-delivery™ technology. Plus the following NEW features:
For existing t:slim X2 insulin pump users, you will receive communication from AMSL Diabetes with more information with your steps to updating your pump software.
For individuals who wish to start pumping, the t:slim X2 insulin pump can now also be purchased with Control-IQ software installed. We would recommend speaking to your healthcare professional to start this process.
ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE. Read the warnings available on amsldiabetes.com.au/resources before purchasing. Consult your healthcare professional to see which product is right for you.
About AMSL Diabetes
AMSL Diabetes is dedicated to helping people live well with diabetes. For over 20 years, AMSL Diabetes has given thousands of people the tools and support they need to improve their quality of life. AMSL Diabetes provides a range of diabetes products to individuals living with diabetes and the healthcare professionals that support them including t:slim X2 Insulin Pumps, Dexcom CGM Systems, OneTouch Blood Glucose Systems and other diabetes accessories. For more information, visit amsldiabetes.com.au.
“Control-IQ technology is an advanced hybrid closed-loop technology that helps to keep glucose levels in range (3.9 to 10 mmol/L) by predicting glucose levels 30 minutes ahead and adjusting insulin delivery according, to help prevent both high and low glucose events.”
Now you can get all the latest news and updates of our products, events and resources right into your inbox.
We are always happy to help, send us a message or enquiry